ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities listed.

December 5, 2003

Clinical Societies, Patient Groups Need New Alliance, Glick Proposes to ASCO

May 24, 1996

Huebner Retires, Named Scientist Emeritus

November 19, 1982

In Brief: Clearinghouse Charter Renewed For Two Years; Good On China, Carbone On Communciation

May 26, 1978

Conversation with The Cancer Letter: Is Republican Control Better Than Two-Party Stalemate?

December 19, 2014

Navelbine+Herceptin: 78% Response In Breast Cancer

November 29, 2002